HCV Management Program Offers Triple Therapy Regimen | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Living with Hepatitis C: How to Prevent and Stop Nosebleeds

Back to News Homepage
Next

Better Hepatitis C Treatment Outcome for Coffee Drinkers

HCV Management Program Offers Triple Therapy Regimen

The Editors at Hepatitis Central
June 22, 2011

Print this page

Because they offer hope of an improved success rate, Axium’s HEPVisions® Program now includes the two recently approved drugs into Hepatitis C treatment.

New Hepatitis C Drugs to their HEPVisionsSM Therapy Management Program

(OPENPRESS) June 14, 2011 — The announcement comes on the heels of the FDA’s approval of Merck’s VictrelisTM and Vertex’s IncivekTM. Both drugs are approved for use in combination with peg interferon and ribavirin, creating a triple therapy regimen. Clinical trials have shown that using one of the two new drugs along with peg interferon and ribavirin drugs is more effective at producing a sustained virological response (SVR).

“Axium is pleased to add VictrelisTM and IncivekTM to the HEPVisionsSM program,” said Mark Montgomery, President and CEO of Axium Healthcare Pharmacy. “The new triple therapy regimen is complex and expensive. Careful patient education, monitoring, and adherence are keys to successful treatment.”

Continue reading this entire article:
http://www.theopenpress.com/index.php?a=press&id=107323

No Comments - be the first!
Share
Share
Previous

Living with Hepatitis C: How to Prevent and Stop Nosebleeds

Back to News Homepage
Next

Better Hepatitis C Treatment Outcome for Coffee Drinkers

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.